The brief

Analyst view

• Cognixion raised $32.2M over 11 funding rounds, with latest $4M convertible note in February 2026.
• The Axon-R headset is for research use only and not yet FDA or Health Canada approved; clinical trials with ALS patients are recruiting.
• Axon-R offers 16-channel EEG with ssVEP classifier and real-time brain-computer interface with AR overlay.

Technical approach

As reported

EEG Sensing

Research-grade brain signals

Axon-R captures 16 channels of physiological data at 2 kHz over Wi-Fi, with occipital sensors for visual-evoked potentials.

Classification

Steady-state visually evoked potential (ssVEP) decoding

Built-in ssVEP classifier interprets brain signals into commands without training, enabling communication and control for people with paralysis.

AR Interface

Augmented reality overlay

AR display lets users interact with content via gaze and brain signals, with onboard AI assistance for communication.

Distribution

Blackrock Neurotech partnership

As of May 2025, Blackrock Neurotech offers Axon-R to research institutions through its distribution network, expanding academic and clinical access.

Show all 4